Incidence and Risk Factors for Residual Adverse Events Despite Anticoagulation in Atrial Fibrillation: Results From Phase II/III of the GLORIA‐AF Registry

Incidence and Risk Factors for Residual Adverse Events Despite Anticoagulation in Atrial Fibrillation: Results From Phase II/III of the GLORIA‐AF Registry

Background Residual risk of ischemic stroke despite anticoagulation in patients with atrial fibrillation (AF) represents a significant clinical issue that remains unaddressed. We aimed to evaluate the incidence and risk factors for residual adverse events in AF. Methods and Results Using data from p...

Full description

Bibliographic Details
Main Authors: Wern Yew Ding, Deirdre A. Lane, Dhiraj Gupta, Menno V. Huisman, Gregory Y. H. Lip
Format: Article
Language:English
Published: Wiley 2022-08-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
adverse events
anticoagulation
ischemic stroke
newly diagnosed atrial fibrillation
predictors
residual risk
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.122.026410

Internet

https://www.ahajournals.org/doi/10.1161/JAHA.122.026410

Similar Items